Macrophage Pharma Company
Reprogramming macrophages to tackle diseases, e.g. oncology and inflammation (inflammosome inhibitor in a pipeline).
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Register and Claim Ownership